CTGF as a multifunctional molecule for cartilage and a potential drug for osteoarthritis
CTGF is a multifunctional protein and plays different roles in different cells and under different conditions. Pamrevlumab, a monoclonal antibody against CTGF, is an FDA approved drug for idiopathic pulmonary fibrosis (IPF) and Duchenne muscular dystrophy (DMD). Recent studies have shown that CTGF a...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Jezik: | English |
| Izdano: |
Frontiers Media S.A.
2022-10-01
|
| Serija: | Frontiers in Endocrinology |
| Teme: | |
| Online dostop: | https://www.frontiersin.org/articles/10.3389/fendo.2022.1040526/full |